(Q48454849)
Statements
1 reference
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy. (English)
1 reference
M C Genovese
1 reference
M Schiff
1 reference
M Luggen
1 reference
J-C Becker
1 reference
R Aranda
1 reference
J Teng
1 reference
T Li
1 reference
N Schmidely
1 reference
M Le Bars
1 reference
M Dougados
1 reference
5 October 2007
1 reference
67
1 reference
4
1 reference
547-554
1 reference